Cells,
Год журнала:
2024,
Номер
13(17), С. 1424 - 1424
Опубликована: Авг. 26, 2024
Cytoprotective
and
neurotoxic
kynurenines
formed
along
the
kynurenine
pathway
(KP)
were
identified
as
possible
therapeutic
targets
in
various
neuropsychiatric
conditions.
Memantine,
an
adamantane
derivative
modulating
dopamine-,
noradrenaline-,
serotonin-,
glutamate-mediated
neurotransmission
is
currently
considered
for
therapy
dementia,
psychiatric
disorders,
migraines,
or
ischemia.
Previous
studies
have
revealed
that
memantine
potently
stimulates
synthesis
of
neuroprotective
kynurenic
acid
(KYNA)
vitro
via
a
protein
kinase
A-dependent
mechanism.
Here,
effects
acute
prolonged
administration
on
brain
functional
changes
cerebral
KP
assessed
rats
using
chromatographic
enzymatic
methods.
Five-day
but
not
single
treatment
with
selectively
activated
cortical
towards
KYNA.
KYNA
increases
accompanied
by
moderate
decrease
tryptophan
(TRP)
L-kynurenine
(L-KYN)
concentrations
without
3-hydroxykynurenine
(3-HK)
levels.
Enzymatic
activity
biosynthetic
enzymes
ex
vivo
was
stimulated
after
memantine.
As
does
directly
stimulate
KATs'
proteins,
higher
KATs
most
probably
results
from
increased
expression
respective
genes.
Noteworthy,
KYNA,
3-HK,
TRP,
L-KYN
striatum,
hippocampus,
cerebellum
affected.
Selective
increase
seems
to
represent
one
mechanisms
underlying
clinical
efficacy
It
tempting
hypothesize
combination
drugs
could
strongly
boost
provide
more
effective
option
treating
pathologies
at
early
stages.
Further
should
evaluate
this
issue
experimental
animal
models
under
scenarios.
Trends in Pharmacological Sciences,
Год журнала:
2023,
Номер
44(7), С. 442 - 456
Опубликована: Май 27, 2023
Lymphocytes
maturing
in
the
thymus
(T
cells)
are
key
factors
adaptive
immunity
and
regulation
of
inflammation.
The
kynurenine
pathway
tryptophan
metabolism
includes
several
enzymes
compounds
that
can
modulate
T
cell
function,
but
manipulating
these
pharmacologically
has
not
achieved
expected
therapeutic
activity
for
treatment
autoimmune
disorders
cancer.
With
increasing
knowledge
other
pathways
interacting
with
kynurenines,
expansion
screening
methods,
application
virtual
techniques
to
understanding
enzyme
structures
mechanisms,
details
interactions
between
kynurenines
being
revealed.
This
review
surveys
some
alternative
approaches
influence
function
indirectly
via
summarizes
most
recent
work
on
development
acting
directly
pathway.
International Journal of Molecular Sciences,
Год журнала:
2023,
Номер
24(6), С. 5742 - 5742
Опубликована: Март 17, 2023
The
tryptophan
and
kynurenine
pathway
is
well-known
to
play
an
important
role
in
nervous,
endocrine,
immune
systems,
as
well
the
development
of
inflammatory
diseases.
It
has
been
documented
that
some
metabolites
are
considered
have
anti-oxidative,
anti-inflammatory,
and/or
neuroprotective
properties.
Importantly,
many
these
may
possess
immune-regulatory
properties
could
alleviate
inflammation
response.
abnormal
activation
might
be
involved
pathophysiological
process
various
immune-related
diseases,
such
bowel
disease,
cardiovascular
osteoporosis,
polycystic
ovary
syndrome.
Interestingly,
brain
memory
system
intricate
immunity
via
modulation
glial
function.
In
further
deliberation
this
concept
with
engram,
roles
gut
microbiota
lead
remarkable
treatments
for
prevention
therapeutics
intractable
Cancers,
Год журнала:
2023,
Номер
15(11), С. 2895 - 2895
Опубликована: Май 24, 2023
The
mechanisms
underlying
a
relationship
between
inflammation
and
cancer
are
unclear,
but
much
emphasis
has
been
placed
on
the
role
of
tryptophan
metabolism
to
kynurenine
downstream
metabolites,
as
these
make
substantial
contribution
regulation
immune
tolerance
susceptibility
cancer.
proposed
link
is
supported
by
induction
indoleamine-2,3-dioxygenase
(IDO)
or
tryptophan-2,3-dioxygenase
(TDO),
in
response
injury,
infection
stress.
This
review
will
summarize
pathway
then
focus
bi-directional
interactions
with
other
transduction
pathways
cancer-related
factors.
can
interact
modify
activity
many
systems,
potentially
generating
an
extended
web
effects
than
direct
its
metabolites.
Conversely,
pharmacological
targeting
those
systems
could
greatly
enhance
efficacy
changes
pathway.
Indeed,
manipulating
interacting
affect
inflammatory
status
tumor
development
indirectly
via
pathway,
while
modulation
influence
anti-cancer
protection.
While
current
efforts
progressing
account
for
failure
selective
IDO1
inhibitors
inhibit
growth
devise
means
circumventing
issue,
it
clear
that
there
wider
factors
involving
kynurenines
merit
detailed
consideration
alternative
drug
targets.
Abstract
Alterations
in
the
kynurenine
pathway
of
tryptophan
metabolism
have
been
implicated
pathophysiology
schizophrenia.
Here,
we
performed
an
in-depth
analysis
all
metabolites
pathway,
i.e.,
(TRY),
kynurenic
acid
(KYNA),
L-kynurenine
(KYN),
3-hydroxykynurenine
(3-HK),
anthranylic
(ANA),
3-hydroxyanthranylic
(3-HANA),
xanthurenic
(XA)
and
quinolinic
(QUINA),
postmortem
samples
dorsolateral
prefrontal
cortex
(DLPFC,
Brodmann
area
46,
9)
individuals
affected
by
schizophrenia
non-schizophrenic
controls.
The
was
carried
out
gray
white
matter.
Levels
KYN,
3-HK,
ANA,
3-HANA
were
significantly
increased
both
matter
DLPFC
schizophrenia,
whereas
levels
TRY,
KYNA,
QUINA
exclusively
remained
unchanged
These
increases
did
not
correlate
with
age,
sex,
duration
disease,
type
antipsychotic
medication.
findings
suggest
that
two
major
branches
transamination
KYN
into
hydroxylation
3-HK
are
activated
perhaps
as
a
result
neuroinflammation,
support
evidence
abnormalities
consistenly
associated
European Journal of Cell Biology,
Год журнала:
2024,
Номер
103(2), С. 151418 - 151418
Опубликована: Май 8, 2024
The
nervous
and
immune
systems
are
highly
developed,
each
performs
specialized
physiological
functions.
However,
they
work
together,
their
dysfunction
is
associated
with
various
diseases.
Specialized
molecules,
such
as
neurotransmitters,
cytokines,
more
general
metabolites,
essential
for
the
appropriate
regulation
of
both
systems.
Tryptophan,
an
amino
acid,
converted
into
functional
molecules
serotonin
kynurenine,
which
play
important
roles
in
role
kynurenine
metabolites
neurodegenerative
psychiatric
diseases
has
recently
received
particular
attention.
Recently,
we
found
that
hyperactivity
pathway
a
critical
risk
factor
septic
shock.
In
this
review,
first
outline
neuroimmune
interactions
tryptophan
derivatives
then
summarized
changes
metabolism
neurological
disorders.
Finally,
discuss
potential
therapeutic
targets
International Immunology,
Год журнала:
2024,
Номер
unknown
Опубликована: Июнь 13, 2024
Abstract
The
intricate
and
dynamic
tryptophan
(Trp)
metabolic
pathway
in
both
the
microbiome
host
cells
highlights
its
profound
implications
for
health
disease.
This
involves
complex
interactions
between
cellular
bacteria
processes,
producing
bioactive
compounds
such
as
5-hydroxytryptamine
(5-HT)
kynurenine
derivatives.
Immune
responses
to
Trp
metabolites
through
specific
receptors
have
been
explored,
highlighting
role
of
aryl
hydrocarbon
receptor
inflammation
modulation.
Dysregulation
this
is
implicated
various
diseases,
Alzheimer’s
Parkinson’s
mood
disorders,
neuronal
autoimmune
diseases
multiple
sclerosis
(MS),
cancer.
In
article,
we
describe
impact
5-HT,
Trp,
indole,
on
Furthermore,
review
microbiome-derived
that
affect
immune
contribute
maintaining
homeostasis,
especially
an
experimental
encephalitis
model
MS.
American Journal of Psychiatry,
Год журнала:
2025,
Номер
182(4), С. 389 - 400
Опубликована: Апрель 1, 2025
Schizophrenia
is
a
neurodevelopmental
disorder
characterized
by
an
excessive
loss
of
synapses.
Kynurenic
acid
(KYNA),
neuroactive
metabolite
tryptophan
along
the
kynurenine
pathway,
can
induce
schizophrenia-related
phenotypes
in
rodents,
and
clinical
studies
have
revealed
elevated
KYNA
levels
CNS
individuals
with
schizophrenia.
However,
factors
that
cause
schizophrenia,
mechanisms
which
contributes
to
pathophysiology,
remain
largely
elusive.
The
authors
used
patient-derived
cellular
modeling
test
hypothesis
microglia-mediated
synapse
engulfment
reducing
neuronal
activity.
Patient-derived
induced
pluripotent
stem
cells
were
generate
2D
cultures
neurons
microglia-like
cells,
as
well
forebrain
organoids
innately
developing
microglia,
study
how
influences
synaptic
activity
microglial
uptake
structures.
To
verify
experimental
data
context,
large-scale
developmental
postmortem
brain
tissue
genetic
datasets
coexpression
networks
for
KYNA-producing
aminotransferases
(KATs)
regarding
enrichment
common
schizophrenia
risk
variants
functional
annotations.
In
these
models,
structures
inhibition
endogenous
production
led
decrease
internalization
synapses
microglia.
integrated
transcriptomic
showed
KATs
enriched
genes
governing
Together,
results
link
activity-dependent
material
while
implicating
pharmacological
strategy
avoid
Cells,
Год журнала:
2023,
Номер
12(7), С. 1087 - 1087
Опубликована: Апрель 4, 2023
Several
studies
show
that
genetic
and
environmental
factors
contribute
to
the
onset
progression
of
neurodevelopmental
disorders.
Maternal
immune
activation
(MIA)
during
gestation
is
considered
one
major
driving
this
process.
The
kynurenine
pathway
(KP)
a
route
essential
amino
acid
L-tryptophan
(Trp)
catabolism
in
mammalian
cells.
Activation
KP
following
neuro-inflammation
can
generate
various
endogenous
neuroactive
metabolites
may
impact
brain
functions
behaviors.
Additionally,
neurotoxic
excitotoxicity
cause
long-term
changes
trophic
support,
glutamatergic
system,
synaptic
function
activation.
Therefore,
investigating
role
neurodevelopment
will
likely
promote
further
understanding
additional
pathophysiology
disorders,
including
autism
spectrum
disorder
(ASD).
In
review,
we
describe
metabolism
pregnancy
represent
how
maternal
inflammation
influence
development.
We
overview
patients
with
ASD
clinical
data
animal
models
designed
verify
perinatal
elevation
long-lasting
biochemical,
neuropathological,
behavioral
deficits
later
life.
Our
review
help
shed
light
on
new
therapeutic
strategies
interventions
targeting
for
Cancers,
Год журнала:
2024,
Номер
16(10), С. 1921 - 1921
Опубликована: Май 18, 2024
Cancer
cachexia
is
a
multifaceted
syndrome
that
impacts
individuals
with
advanced
cancer.
It
causes
numerous
pathological
changes
in
cancer
patients,
such
as
inflammation
and
metabolic
dysfunction,
which
further
diminish
their
quality
of
life.
Unfortunately,
also
increases
the
risk
mortality
affected
individuals,
making
it
an
important
area
focus
for
research
treatment.
Several
potential
nutritional
therapies
are
being
tested
preclinical
clinical
models
efficacy
improving
muscle
metabolism
patients.
Despite
promising
results,
no
special
have
yet
been
validated
practice.
Multiple
studies
provide
evidence
benefits
increasing
protein
synthesis
through
increased
intake
amino
acids
or
protein.
There
exercise
can
reduce
atrophy
by
modulating
synthesis.
Therefore,
combination
may
be
more
effective
cachexia.
This
review
provides
overview
approaches
use
without
therapy
to
improve